ISSN: 0974-276X
Journal of Proteomics & Bioinformatics
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

How to Solve Complex Scientific Challenges with Comprehensive Proteomics and Bioinformatics means - HUPO Brain Proteome Project

Christian Stephan*, Michael Hamacher, Helmut E. Meyer
Medizinisches Proteom-Center, Ruhr-Universität Bochum, ZKF E.143, Universitätsstraße 150, D-44801 Bochum
Corresponding Author : Dr. Christian Stephan,
Medizinisches Proteom-Center, Ruhr-Universität Bochum,
ZKF E.143,Universitätsstraße 150, D- 44801 Bochum,
Tel         : + 49234 32 29264,
E-mail  : christian.stephan@rub.de
Received April 02, 2008; Accepted April 09, 2008; Published April 20, 2008
Citation: Christian S, Michael H, Helmut EM (2008) How to Solve Complex Scientific Challenges with Comprehensive Proteomics and Bioinformatics means - HUPO Brain Proteome Project. J Proteomics Bioinform 1: 001-002. doi:10.4172/jpb.1000001
Copyright: © 2008 Christian S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Journal of Proteomics & Bioinformatics

HUPO - How it Began
Since more than a decade proteomics is the method of choice for the life science sector as genetics could not cure all human diseases. Unfortunately, the world of proteins is far more complex than the genome; and a proper analysis can be extremely expensive and time consuming. In addition, the need of standards, standard operation procedures (SOPs) and common rules is obvious. Therefore, the Human Proteome Organisation (HUPO, www.hupo.org) was founded in 2001 aiming at the optimisation, the spreading of proteomics techniques and demonstrating its potentials. In order to focus the expertises of the participating scientists, tissue-related initiatives got together under the roof of HUPO that voluntarily analysed one distinct human organ with proteomics means. The very first initiatives were the HUPO Plasma Proteome Project (HUPO PPP or HPPP), the HUPO Brain Proteome Project (HUPO BPP/HBPP) as well as the HUPO Liver Proteome Project (HUPO LPP/HLPP). During the last seven years, several initiatives were added (as to end of 2007), namely the Human Antibody Initiative (HAI), the Mouse Models of human Disease (MMHD), the Human Disease Glycomics/Proteome Initiative (HGPI), the HUPO Cardiovascular Initiative (HUPO CVI), the Proteome Biology of Stem Cells Initiative and the Proteomics Standards Initiative (HUPO PSI, www.psidev.info), defining proteomics controlled vocabularies as well as common standards. HUPO has developed criteria for new initiatives to be found at HUPO´s homepage.
The HUPO Brain Proteome Project and the Challenges
The prevalence of neurodegenerative diseases especially in Western societies increases steadily - and so does the costs for comprehensive scientific proteomics studies. This is due to immense expenses for equipment and consumables as well as the high number of repetitions to fulfil the statistical imperative. At the same time, techniques become even more complex, while suitable samples are scarce, especially when thinking of the human brain. What is the consequence?
As indicated above, the Brain Proteome Project (BPP) is one of the initial initiatives of HUPO aiming solving these problems. The HUPO BPP started its operational work in early 2003. An administration and bioinformatics group was initiated at the Medizinisches Proteom-Center in Bochum, Germany. It became clear soon that common standards and defined parameters were missing as most scientists defined their own thresholds, parameters and specifications, mostly due to different analysis set-ups. However, these different criteria led to different results, so that studies can not be compared easily. During the 1st HUPO BPP Workshop at Castle Mickeln, Germany, two pilot studies were initiated, also inspired by the experiences of the HUPO PPP colleagues. The aims and results of these two studies are described in detail in the special edition The HUPO Brain Proteome Project– Concerted Analysis of the Brain [PROTEOMICS, volume 6, issue 18]. The studies lasted more than two years as data generated in single labs was collected in a Data Collection Center and was bioinformatically analysed centrally afterwards. Especially the participating lab scientists and the bioinformatic task force, greatly supported by the HUPO PSI, did an outstanding job. Due to the combined effort of 18 laboratories world wide a huge amount of data sets with current proteomics technologies were gained and analyzed. Only very few of the identified differentially expressed proteins could be found combined effort of 18 laboratories world wide a huge amount of data sets with current proteomics technologies were gained and analyzed. Only very few of the identified differentially expressed proteins could be found by many or all of the participating groups, although each of the individual laboratories could show to have detected several dozens of reproducible differences. The yield of an individual protein is depending on the conditions for sample preparation, i.e. salt concentration, pH, detergents, temperature, etc. Every little change will result in a different sample composition and thus another protein set. Here, once again the need for standards became obvious when thinking of sample handling or parameters for search engines in mass spectrometry, but also the power of synergistic work of different analysis strategies. Moreover it is important to repeat experiments independently several times to show their reproducibility as it was already suggested in many articles before - but this is often unconsidered despite the own experiences.The subsequent consolidation phase has been accompanied by several workshops dedicated to the spreading of the standard concepts and to the collection of existing approaches within brain proteomics. Concerning the criteria that have to be fulfilled in successful proteomics it was stated that:
- methods have to be robust, so that e.g. the same system can be run several times
- methods have to show a high sensitivity, so that e.g. low abundant proteins can be detected
- methods should be available at reasonable cost (for academic institutes) allowing independent   biological repetitions
- each laboratory has to show the reproducibility of every result
-It is therefore clear that high performance has to be estimated higher than high throughput.
The work on bioinformatics standards is now carried on also by the HUPO PSI as well as the Proteomics Data Collection – ProDaC, an EU funded consortium (www.psidev.info and www.fp6-prodac.eu)
Redundant Telephone Lists
Many, probably disease-unspecific proteins are identified in numerous studies, superposing the key player proteins of neurodegenerative diseases we are interested in. A lot of protein expression changes are usually reported in numerous models or human tissue studies, ending up with protein lists that resemble each other. Only a few of them seem to be disease-specific regulated proteins or genes. Klose and his colleagues from the Charité Berlin, Germany, propose that the observed protein changes might partially be explained by a proteomic network response. They consider a class of balancer proteins within the proteomic network, defined as proteins that buffer changes within the protein stoichiometry. The loss or the change in the amount of essential proteins will lead to a disturbance of the protein composition. This may cause a system malfunction that can be compensated partly by the expression of other, disease-unspecific proteins. These proteins are named as balancer proteins, also showing significant regulation, but being probably not involved in the development of the disease. The expression of these proteins could be regulated in a defined manner, compensating the changed overall protein amount in the cell or cell compartment. However, the triggered effect could have a high influence by increasing or decreasing the amount of some effector related proteins, controlled by protein regulatory networks which underlie these mechanisms of resilience biology. The balancer proteins might essentially contribute to the overall network entropy and can be named hubs of these protein regulatory networks. By comparison and integration of all data available from those studies it may turn out that most of the reported proteins/genes are found in many of those different investigations, in other words they are not specific for the particular study and disease, respectively. Only large scale analyses as the HUPO BPP, integrating many different quantitative research fields, will distinguish between real effector proteins as disease biomarkers and balancer proteins. Therefore, one has to look on a variety of diseases to discriminate if a protein is diseasespecific. The integration of all available scientific fields including proteomics, genomics and molecular biology will allow achieving essential insight about how cellular activities are regulated.
Outlook
The era of post identified information has begun, focusing on bioinformatics and systems biology. Large consortia as the HUPO BPP are necessary for such complex interdisciplinary research to overcome the problem of the necessary amount of data for biological interpretation in a system biology driven way. The gained complementary result lists as a part of the telephone book will be interpreted by systems biological means to overcome static identification lists. These efforts have to be based on comprehensive differential analyses using complementary methods and common standards. Only by combining several techniques (MS, ISH, ProteinBiochips etc.) and results from several Omics an understanding of e.g. complex brain diseases will be possible in the near future. The HUPO BPP and HUPO itself will elaborate suitable standards to collect data of many laboratories to build the mandatory fundaments of systems biology driven approaches and will help actively to realise these insights. However, the academic scientific research today needs barrier free data and publication access beside money, courage and self-criticism to bear new outstanding ideas.
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc Applications of Bioinformatics
Disc Bacterial transcriptome
Disc Bioinformatics Algorithms
Disc Bioinformatics Databases
Disc Bioinformatics Tools
Disc Cancer Pharmacogenomics
Disc Cancer Proteomics
Disc Clinical Pharmacogenomics
Disc Clinical Proteomics
Disc Cluster analysis
Disc Comparative genomics
Disc Comparative proteomics
Disc Comparative transcriptomics
Disc Computational drug design
Disc Current Proteomics
Disc Data algorithms
Disc Data mining applications in genomics
Disc Data mining applications in proteomics
Disc Data mining in drug discovery
Disc Data mining tools
Disc Data modelling and intellegence
Disc Data warehousing
Disc Drug Dosage Formulations
Disc Drug Toxicity and Efficacy
Disc Epigenetics
Disc Epigenomic studies
Disc Gene Expression profiling
Disc Gene polymorphism
Disc Genome annotation
Disc Genomic Targets
Disc Genomic data mining
Disc Genomic data warehousing
Disc Glycome
Disc Human Proteome Project Applications
Disc Immune Disorders
Disc Individualized Medicine
Disc Mapping of genomes
Disc Mass Spectrometry in Proteomics
Disc Meta genomics
Disc Metabolome
Disc Microarray
Disc Microarray Proteomics
Disc Molecular and Cellular Proteomics
Disc Mouse transcriptome
Disc Non coding MRNA
Disc Personalized Medicine Studies
Disc Pharmacoeconomics in Drug Development
Disc Pharmacogenetics
Disc Pharmacogenomic Biomarker
Disc Pharmacogenomics Applications
Disc Pharmacogenomics Future Medicine
Disc Pharmacogenomics and Personalized Medicine
Disc Pharmacogenomics for Patient Care
Disc Pharmacoproteomics in Drug development
Disc Profiling
Disc Protein Sequence Analysis
Disc Protein engineering
Disc Proteogenomics
Disc Proteome
Disc Proteome Profiling
Disc Proteomic Analysis
Disc Proteomic Biomarkers
Disc Proteomics Clinical Applications
Disc Proteomics Research
Disc Proteomics Science
Disc Proteomics and Pharmacodynamics
Disc Proteomics data warehousing
Disc Python for Bioinformatics
Disc Quantitative Proteomics
Disc RNA sequencing
Disc RNA sequencing and analysis
Disc Sequencing
Disc Small RNA Sequencing
Disc Statistical data mining
Disc Transcripotme
Disc Transcriptional Attenuation
Disc Transcriptional Regulation
Disc Transcriptome analysis
Disc Translational Medicine
 
Recommended Journals
Disc Transcriptomics Journal
Disc Pharmacogenomics Journal
Disc Data Mining Journal
  View More»
 
Recommended Conferences
Disc 6th Bioinformatics Conference
August 22-23, 2016 Philadelphia, Pennsylvania, USA
Disc 7th International Conference and Expo on Proteomics
October 24-26, 2016 Rome, Italy
View More»
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11162
  [From(publication date):
April-2008 - Jul 01, 2016]
  Breakdown by view type
  HTML page views : 7433
  PDF downloads :3729
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version